首页|研究传统抗结核药物联合糖皮质激素治疗结核性胸膜炎的临床效果

研究传统抗结核药物联合糖皮质激素治疗结核性胸膜炎的临床效果

扫码查看
目的 观察传统抗结核药物联合糖皮质激素治疗结核性胸膜炎的可行性,以为临床相关研究提供有益参考。方法 选取结核性胸膜炎患者 70 例为研究对象,遵循抽签的方法将患者分为对照组(34 例)和观察组(36 例)。对照组给予传统抗结核药物治疗,观察组在对照组基础上联合糖皮质激素治疗。对比两组治疗前后临床相关指标、胸腔积液中炎性因子水平、肺功能及临床效果。结果 观察组治疗总有效率88。89%比对照组的64。71%更高(P<0。05)。两组治疗后胸腔积液厚度比同组治疗前更低,且观察组治疗后胸腔积液厚度(1。12±0。26)mm比对照组的(1。35±0。29)mm更低(P<0。05)。观察组引流时间(7。38±1。01)d比对照组的(11。65±1。30)d更短(P<0。05)。治疗后,对照组胸腔积液中肿瘤坏死因子-α、白细胞介素-2、白细胞介素-17 水平分别为(158。39±17。10)、(311。27±23。15)、(42。27±4。19)pg/ml,观察组分别为(117。86±13。72)、(286。51±21。90)、(35。96±3。05)pg/ml。两组治疗后胸腔积液中肿瘤坏死因子-α、白细胞介素-2、白细胞介素-17 水平比同组治疗前更低,且观察组治疗后比对照组更低(P<0。05)。治疗后,对照组第 1 秒用力呼气容积与用力肺活量的比值(FEV1/FVC)、第一秒用力呼气容积(FEV1)占预计值百分比、最大吸气压力分别为(67。54±8。30)%、(79。81±7。75)%、(95。14±18。65)cm H2O(1 cm H2O=0。098 kPa),观察组分别为(71。19±5。05)%、(83。70±6。42)%、(106。83±19。11)cm H2O。两组治疗后FEV1/FVC、FEV1 占预计值百分比、最大吸气压力比同组治疗前更高,且观察组治疗后比对照组更高(P<0。05)。结论 传统抗结核药物联合糖皮质激素治疗结核性胸膜炎患者具有较为理想的效果,其能够缩短患者引流时间,减少胸腔积液厚度,降低炎性水平,继而促进肺功能早日恢复。
Study the clinical effect of traditional anti-tuberculosis drugs combined with glucocorticoids in the treatment of tuberculous pleurisy
Objective To observe the feasibility of traditional anti-tuberculosis drugs combined with glucocorticoids in the treatment of tuberculous pleurisy,so as to provide useful reference for clinical research.Methods 70 patients with tuberculous pleurisy were selected as the study subjects,and were divided into a control group(34 cases)and an observation group(36 cases)according to lottery method.The control group was treated with traditional anti-tuberculosis drugs,and the observation group was treated with glucocorticoid based on the control group.The clinical indicators,levels of inflammatory factors in pleural effusion and lung function before and after treatment,and clinical effects of the two groups were compared.Results The total effective rate of 88.89%in the observation group was higher than 64.71%in the control group(P<0.05).After treatment,the thickness of pleural effusion in the two groups was lower than that before treatment in this group,and the thickness of pleural effusion of(1.12±0.26)mm in the observation group was lower than(1.35±0.29)mm in the control group(P<0.05).The drainage time of(7.38±1.01)d in the observation group was shorter than(11.65±1.30)d in the control group(P<0.05).After treatment,the levels of tumor necrosis factor-α,interleukin-2,and interleukin-17 in pleural effusion of the control group were(158.39±17.10),(311.27±23.15),and(42.27±4.19)pg/ml,and those of the observation group were(117.86±13.72),(286.51±21.90),and(35.96±3.05)pg/ml.After treatment,the levels of TNF-α,interleukin-2 and interleukin-17 in pleural effusion of the two groups were lower than those before treatment,and the observation group was lower than the control group(P<0.05).After treatment,the ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC),forced expiratory volume in one second(FEV1)as a percentage of the predicted value,and maximal inspiratory pressure of the control group were(67.54±8.30)%,(79.81±7.75)%,and(95.14±18.65)cm H2O(1 cm H2O=0.098 kPa),while those of the observation group were(71.19±5.05)%,(83.70±6.42)%,and(106.83±19.11)cm H2O.After treatment,FEV1/FVC,FEV1 as a percentage of the predicted value,and maximal inspiratory pressure in both groups were higher than those before treatment,and the observation group was higher than the control group(P<0.05).Conclusion Traditional anti-tuberculosis drugs combined with glucocorticoids for patients with tuberculous pleurisy has a more satisfactory effect,which can shorten the drainage time of patients,reduce the thickness of pleural effusion,reduce the level of inflammation,and then promote the early recovery of lung function.

Traditional anti-tuberculosis drugsGlucocorticoidsTuberculous pleurisyLung functionClinical effect

李娜

展开 >

274000 菏泽市传染病医院

传统抗结核药物 糖皮质激素 结核性胸膜炎 肺功能 临床效果

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(22)